Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year
References
- Haxhihamza K, Arsova S, Bajraktarov S, Kalpak G, Stefanovski B, Novotni A, Milutinovic M. Patient Satisfaction with Use of Telemedicine in University Clinic of Psychiatry: Skopje, North Macedonia During COVID-19 Pandemic. Telemed, J E Health. 27(4):464-467, 2021
- Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21, 335–337
- Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J. et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J. Infect. 81, e16–e25, 2020
- Richards, M., Anderson, M., Carter, P., Ebert, B. L. & Mossialos, E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 1:565–567, 2020
- Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis: a national population based modelling study. Lancet Oncol. 21:1023–1034, 2020.
- Sud, A., Torr, B., Jones, M. E., Broggi, J., Scott, S., Loveday, C., Garrett, A., Gronthoud, F., Nicol, D. L., Jhanji, S., Boyce, S. A., Williams, A., Riboli, E., Muller, D. C., Kipps, E., Larkin, J., Navani, N., Swanton, C., Lyratzopoulos, G., McFerran, E., Lawler, M., Houlston, R. & Turnbull, C. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 21:1034–1044, 2020
- UK Lung Cancer Coalition (UKLCC). COVID-19 Matters: A Review of the Impact of COVID-19 on the Lung Cancer Pathway and Opportunities for Innovation Emerging from the Health System Response to the Pandemic COVID-19 (UKLCC, 2020)
- de Joode K, Dumoulin DW, Engelen V, et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer 136:132-9, 2020
- Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov 10:783–91, 2020
- Helsper, C. W., Campbell, C., Emery, J., Neal, R. D., Li, L., Rubin, G. et al. Cancer has not gone away: a primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19. Eur. J. Cancer Care 29, e13290, 2020
- Khan, N., Jones, D., Grice, A., Alderson, S., Bradley, S., Carder, P. et al. A brave new world: the new normal for general practice after the COVID-19 pandemic. BJGP Open 4, bjgpopen20X101103, 2020
- British Thoracic Society. COVID-19: information for the respiratory community. https://www.brit-thoracic.org.uk/about-us/covid-19-information-for-therespiratory-community/ (2020).
- Horn, L., Whisenant, J. G., Torri, V., Huang, L.-C., Trama, A., Paz-Ares, L. G. et al. Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): impact of type of cancer therapy and COVID therapy on survival. Am. Soc. Clin. Oncol. 38, LBA111, 2020
- Luo, J., Rizvi, H., Preeshagul, I. R., Egger, J. V., Hoyos, D., Bandlamudi, C. et al. COVID-19 in patients with lung cancer. Ann. Oncol. 31, 1386–1396, 2020
- Antonoff, M., Backhus, L., Boffa, D. J., Broderick, S. R., Brown, L. M. et al. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. J. Thorac. Cardiovasc. Surg. 160, 601–605, 2020
- Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement. Radiother Oncol 146:223–9, 2020
- Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy 12:269–73, 2020
- Calabrò L, Peters S, Soria J-C, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 8:542–4, 2020
- Bakhribah H, Zeitouni M, Daghistani RA, et al. Implications of COVID-19 pandemic on lung cancer management: a multidisciplinary perspective. Crit Rev Oncol Hematol 156:103120, 2020
- Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–34, 2020
- Calles, A., Aparicio, M. I., Alva, M., Bringas, M., Gutierrez, N., Soto, J. et al. Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid. Front. Oncol. 10, 1777, 2020
- Thomas Round, Veline L’Esperance, Joanne Bayly et al. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. British Journal of Cancer 125:629–640, 2021.
Language: English
Page range: 105 - 115
Published on: Mar 29, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2023 Simonida Crvenkova, Dragan Jakimovki, Vladimir Ristovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.